Cytodyn
CYDY · OTC
$0.2501+$0.0001 (+0.04%)TodayMarket closed ·
Prev close $0.25
Key indicators
CYDY profitability and balance sheet ratios
EPS -$0.0144 in Aug 2026, against -$0.0044 a year earlier.
| Period | EPS |
|---|---|
| Nov 2024 | -$0.0039 |
| Feb 2025 | -$0.0039 |
| May 2025 | -$0.0048 |
| Aug 2025 | -$0.0044 |
| Nov 2025 | -$0.0179 |
| Feb 2026 | -$0.0037 |
| May 2026 | -$0.0072 |
| Aug 2026 | -$0.0144 |
Income statement
No financial statements are reported for Cytodyn.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|
| Total assets | $18.5M | $14.0M | $19.1M |
| Total liabilities | $122.8M | $123.7M | $117.1M |
| Shareholder equity | −$104.3M | −$109.7M | −$98.1M |
| Cash and short-term investments | $15.7M | $11.9M | $16.4M |
| Total debt | $27.2M | $27.2M | $27.2M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.